アビバクタムナトリウムのＣ形

Japanese Patent JP7075884

B2

The present invention relates to crystalline form C of avibactam sodium and to a process for its preparation. The invention also concerns a pharmaceutical composition comprising form C and one or more antibacterial agents, wherein at least one antibacterial agent is a beta-lactam antibiotic. The pharmaceutical composition of the present invention can be used as medicament, in particular for treatment and/or prevention of bacterial infections.

WO/2003/043624	DUAL INHIBITORS OF ADIPOCYTE FATTY ACID BINDING PROTEIN AND KERATINOCYTE FATTY ACID BINDING PROTEIN
WO/2005/030206	ARYL-1,3-AZOLE DERIVATIVES AND METHODS FOR INHIBITING HEPARNASE ACTIVITY
JP2011006439	AZA-HETEROCYCLIC COMPOUND USED TO TREAT NEUROLOGICAL DISORDER AND HAIR LOSS

Hotter, Andreas
Adama, Verena
Brickwar, Hannes

JP2018506919A

May 26, 2022

August 09, 2016

Click for automatic bibliography generation  

SANDOZ AKTIENGESELLSCHAFT

A61K31/427; C07D487/08; A61K31/546; A61K31/551; A61P31/04; A61P43/00

JP2014517027A
JP2003519698A
JP2013507346A

WO2014135930A1
WO2012086241A1

高田則幸,創薬段階における原薬Formスクリーニングと選択,PHARM STAGE,Vol.6, No.10,2007年01月15日,p.20-25
大島寛,結晶多形・擬多形の析出挙動と制御,PHARM STAGE,2007年01月15日,Vol.6, No.10,p.48-53
川口洋子ら,医薬品と結晶多形,生活工学研究,2002年,Vol.4, No.2,p.310-317
BYRN S,PHARMACEUTICAL SOLIDS: A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS,PHARMACEUTICAL RESEARCH,米国,KLUWER ACADEMIC PUBLISHERS,1995年07月01日,V12 N7,P945-954
山野光久,医薬品のプロセス研究における結晶多形現象への取り組み,有機合成化学協会誌,2007年09月01日,Vol.65, No.9,p.907(69)-913(75)
"新医薬品の規格及び試験方法の設定について",医薬審発第568号,2001年05月01日

Kawaguchi International Patent Office

Previous Patent: Trauma treatment device Pressure monitoring and control system

Next Patent: Remote control unit and electric bicycle